Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
HERCULES, Calif.–(BUSINESS WIRE)–Aug 31, 2026–
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lakkaraju, will participate in a fireside chat event during Wells Fargo’s 21 st Annual Healthcare Conference on Wednesday, September 9, 2026, at 3:45 PM Eastern Time (12:45 PM Pacific Time). A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at investors.bio-rad.com . About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,400 employees, and $2.6 billion in revenues in 2025. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety, and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260831154879/en/
CONTACT: Investor Contact:
Ruben Argueta, Investor Relations
510-617-7488
[email protected] Contact:
Anna Gralinska, Corporate Communications
510-741-6643
[email protected]
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: RESEARCH PUBLIC RELATIONS/INVESTOR RELATIONS CLINICAL TRIALS COMMUNICATIONS BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH SCIENCE OTHER SCIENCE
SOURCE: Bio-Rad Laboratories, Inc. Copyright Business Wire 2026. PUB: 08/31/2026 09:00 AM/DISC: 08/31/2026 09:02 AM
http://www.businesswire.com/news/home/20260831154879/en